Your browser doesn't support javascript.
loading
Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience.
Richards, Huw; Chavda, Selina J; Wilson, William; Camilleri, Marquita; Cohen, Oliver; Horder, Jackie; Newrick, Fiona; Papanikolaou, Xenofon; Sive, Jonathan; Lee, Lydia; Popat, Rakesh; Wechalekar, Ashutosh; Kyriakou, Charalampia; Yong, Kwee; Rabin, Neil.
Afiliación
  • Richards H; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Chavda SJ; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Wilson W; Department of Haematology, UCL Cancer Institute, London, UK.
  • Camilleri M; Cancer Research UK & UCL Cancer Trials Centre, London, UK.
  • Cohen O; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Horder J; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Newrick F; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Papanikolaou X; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Sive J; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Lee L; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Popat R; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Wechalekar A; Department of Haematology, UCL Cancer Institute, London, UK.
  • Kyriakou C; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Yong K; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
  • Rabin N; Department of Haematology, University College London Hospitals NHS Foundation Trusts, London, UK.
Leuk Lymphoma ; 62(14): 3544-3547, 2021 12.
Article en En | MEDLINE | ID: mdl-34348069
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido